Immunogenicity of Varicella Zoster Virus DNA Vaccines Encoding Glycoprotein E and Immediate Early Protein 63 in Mice

Immunogenicity of Varicella Zoster Virus DNA Vaccines Encoding Glycoprotein E and Immediate Early Protein 63 in Mice

Herpes zoster (HZ) is caused by the reactivation of latent varicella-zoster virus (VZV) from the sensory ganglia due to aging or immunosuppression. Glycoprotein E (gE) is a widely used vaccine antigen for specific humoral and cellular immune responses. Immediate early protein 63 (IE63) is expressed...

Full description

Bibliographic Details
Main Authors:	Jie Liu, Junyang Lin, Linjun Cai, Jie Sun, Xue Ding, Cenrong Wang, Yanchun Wu, Xiaoling Gao, Weiheng Su, Chunlai Jiang
Format:	Article
Language:	English
Published:	MDPI AG 2022-06-01
Series:	Viruses
Subjects:	herpes zoster glycoprotein E immediate early protein 63 DNA vaccines cell-mediated immunity
Online Access:	https://www.mdpi.com/1999-4915/14/6/1214

Similar Items

Enhanced Potency and Persistence of Immunity to Varicella-Zoster Virus Glycoprotein E in Mice by Addition of a Novel BC02 Compound Adjuvant
by: Junli Li, et al.
Published: (2022-03-01)

Immunogenicity in Mice Immunized with Recombinant Adenoviruses Expressing Varicella-Zoster Virus Envelope Glycoprotein E
by: Yanpeng Zheng, et al.
Published: (2023-11-01)

Immunogenicity of Varicella-Zoster Virus Glycoprotein E Formulated with Lipid Nanoparticles and Nucleic Immunostimulators in Mice
by: Han Cao, et al.
Published: (2021-03-01)

Preclinical immunogenicity of an adenovirus-vectored vaccine for herpes zoster
by: Marta Ulaszewska, et al.
Published: (2023-01-01)

Effect of Routine Varicella Immunization on the Epidemiology and Immunogenicity of Varicella and Shingles
by: Naruhito Otani, et al.
Published: (2022-03-01)

Varicella zoster virus reactivation during or immediately following treatment of tegumentary leishmaniasis with antimony compounds
by: Andrea Barbieri Barros, et al.
Published: (2014-07-01)

Investigation of varicella zoster virus glycoprotein-specific T cell responses
by: Malavige, G, et al.
Published: (2007)

Varicella Zoster Virus-Associated Meningitis as a Rebound Varicella Zoster Disease after Antiviral Discontinuation
by: Tetsuko Sato, et al.
Published: (2021-02-01)

Herpes Simplex Virus and Varicella Zoster Virus Infections in Cancer Patients
by: Ralph Tayyar, et al.
Published: (2023-02-01)

The Association between Varicella Vaccination and Herpes Zoster in Children: A Semi-National Retrospective Study
by: Ester Forer, et al.
Published: (2023-06-01)

Epidemiological characteristics and societal burden of varicella zoster virus in the Netherlands
by: Pierik Jorien GJ, et al.
Published: (2012-05-01)

Herpes Zoster and Immunogenicity and Safety of Zoster Vaccines in Transplant Patients: A Narrative Review of the Literature
by: Lei Wang, et al.
Published: (2018-07-01)

Herpes zoster duplex bilateralis symmetricus in an immunocompromised patient with recent varicella infection
by: Nuntouchaporn Amonchaisakda, et al.
Published: (2021-01-01)

An adult co-presented with varicella and herpes zoster caused by varicella zoster virus genotype J, China: a case report
by: Guangcheng Xie, et al.
Published: (2020-06-01)

Giant cell lichenoid dermatitis within healed varicella zoster site
by: Yara Alghamdi, et al.
Published: (2023-09-01)

VARICELLA-ZOSTER VIRUS INFECTION IN PREGNANCY
by: Geta Vancea, et al.
Published: (2018-09-01)

Swiss recommendations for the management of varicella zoster virus infections
by: R Agosti
Published: (2007-05-01)

Incidence of varicella and herpes zoster after inclusion of varicella vaccine in national immunization schedule in Turkey: time trend study
by: Ahmet Soysal, et al.
Published: (2021-03-01)

Immunogenicity and safety of live attenuated and recombinant/inactivated varicella zoster vaccines in people living with HIV: A systematic review
by: Valentina Carta, et al.
Published: (2024-12-01)

VARICELLA ZOSTER VIRUS AND DISEASES OF CENTRAL NERVOUS SYSTEM VESSELS
by: A. S Kazanova, et al.
Published: (2015-06-01)

Varicella Zoster Infection in Infancy (A Very Rare Case Report)
by: Mohammad Razmyar, et al.
Published: (2020-08-01)

Encefalitis por virus varicela zoster: A propósito de un caso Encephalitis by varicella zoster virus: A propos of a case
by: Alfredo Ediel Misiara Álvarez, et al.
Published: (2009-10-01)

Zoster Sine Herpete: two unusual cases of varicella-zoster reactivation with atypical complaints of acute chest pain and severe headache
by: Yilin Yang, et al.
Published: (2023-04-01)

HERPES ZOSTER
by: Nowshad Khan
Published: (2014-09-01)

Herpes Zoster in an Immunocompetent Child without a History of Varicella
by: Bing-Shiau Shang, et al.
Published: (2021-04-01)

Clinical Features of Varicella-Zoster Virus Infection
by: Peter G. E. Kennedy, et al.
Published: (2018-11-01)

Herpes zoster ophthalmicus with ocular involvement in overtreated hyperthyroidism
by: Surbhi Khurana, et al.
Published: (2020-01-01)

The Spectrum of Neurological Manifestations of Varicella–Zoster Virus Reactivation
by: Peter G. E. Kennedy
Published: (2023-07-01)

Sacral (S1) herpes zoster
by: Chiriac A, et al.
Published: (2019-05-01)

The impact of childhood varicella vaccination on the incidence of herpes zoster in the general population: modelling the effect of exogenous and endogenous varicella-zoster virus immunity boosting
by: Christophe Sauboin, et al.
Published: (2019-02-01)

Varicella zoster virus infections in neurological patients: a clinical study
by: Thomas Skripuletz, et al.
Published: (2018-05-01)

Case Report: Various Clinical Manifestations Caused by Varicella-Zoster Virus in a Family
by: Qinghong Meng, et al.
Published: (2022-06-01)

Reactivation of Herpes Zoster Keratitis Following Shingrix Vaccine
by: Tracy J. Lu, et al.
Published: (2022-02-01)

Mutagenesis of the Varicella-Zoster Virus Genome Demonstrates That VLT and VLT-ORF63 Proteins Are Dispensable for Lytic Infection
by: Shirley E. Braspenning, et al.
Published: (2021-11-01)

Herpes zoster in patients with systemic lupus erythematosus
by: Maria Bibiana Leroux
Published: (2016-10-01)

Herpes zoster in an immunocompetent infant with a history of varicella in early infancy and after a minor injury - case report and literature review
by: Dimić Jovana S., et al.
Published: (2021-01-01)

Manipulation of the Innate Immune Response by Varicella Zoster Virus
by: Chelsea Gerada, et al.
Published: (2020-01-01)

Persistence of immune response to an adjuvanted varicella-zoster virus subunit vaccine for up to year nine in older adults
by: Tino F. Schwarz, et al.
Published: (2018-06-01)

The review gives data on the clinical manifestations, complications, and epidemiological characteristics of herpes zoster.
by: N M Afonina, et al.
Published: (2013-11-01)

Herpes zoster (Shingles)
by: M. H. Motswaledi
Published: (2018-08-01)